|Bid||5.65 x 100|
|Ask||5.90 x 100|
|Day's Range||5.55 - 5.79|
|52 Week Range||3.20 - 17.50|
|PE Ratio (TTM)||-2.03|
|Earnings Date||Aug 3, 2017 - Aug 7, 2017|
|Dividend & Yield||N/A (N/A)|
|1y Target Est||10.00|
NEW YORK, NY / ACCESSWIRE / May 30, 2017 / While still not anywhere the highs of 2015's boom, the Biotech Industry has shown some signs of a comeback in 2017. After a dismal 2016, the iShares NASDAQ Biotechnology ...
Dynavax Technologies Corporation announced today that updated data from an ongoing Phase 1b/2 study investigating SD-101, Dynavax's intratumoral TLR9 agonist, in combination with KEYTRUDA® , an anti-PD-1 ...
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Dynavax Technologies Corp. Here are 5 ETFs with the largest exposure to DVAX-US. Comparing the performance and risk of Dynavax Technologies Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)